
Keywords: AOPPs; advanced oxidation protein products; 5-ASA; 5-aminosalicylic acid; CD; Crohn's disease; CDDS; colon drug delivery system; DAI; disease activity index; DMT-MM; 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride; DSS; dextran sulfate